Abstract
BackgroundImmunological checkpoint blockade is effective in treating various malignancies. Identifying predictive biomarkers to assist patient selection for immunotherapy has become a priority in both clinical and research settings.MethodsMutations in patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have